HG-1230

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1230

Drug Alias NameAIRM1 modulator (Human Genome Sciences)OBP-like modulator (Human Genome Sciences)P75/AIRM1 modulator (Human Genome Sciences)SIGLEC-7 modulator (Human Genome Sciences)SIGLEC-9 modulator (Human Genome Sciences) +[13]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSialic acid-binding Ig-like lectin 9 modulatorsSialic acid-binding Ig-like lectin 7 modulators

TargetsSialic acid-binding Ig-like lectin 9Sialic acid-binding Ig-like lectin 7

Therapy Area/IndicationsImmune System DiseasesNervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A